Literature DB >> 24214658

Mesenchymal origin of multipotent human testis-derived stem cells in human testicular cell cultures.

J V Chikhovskaya1, S K M van Daalen, C M Korver, S Repping, A M M van Pelt.   

Abstract

In contrast to mouse germ cell-derived pluripotent stem cells, the pluripotent state of human testis-derived embryonic stem cell (ESC)-like that spontaneously arise in primary testicular cell cultures remains controversial. Recent studies have shown that these cells closely resemble multipotent mesenchymal stem cells (MSCs), raising the question of their origin and designating these cell populations as multipotent human testis-derived stem cells (mhtSCs) rather than truly ESC-like cells. Here, we evaluate the origin of mhtSCs in vitro by culturing selected testicular cell types. We demonstrate that mhtSCs can be obtained equally efficiently in cultures of pure testicular somatic cells devoid of germ cells. Conversely, cultures with a purified population of germ cells/spermatogonia do not produce any mhtSCs. Based on common molecular characteristics of the somatic starting population and mhtSCs, we conclude that mhtSCs colonies originate from somatic mesenchymal progenitors present in primary testicular cell cultures and do not arise from germ cells undergoing incomplete reprogramming in vitro.

Entities:  

Keywords:  culture-induced reprogramming; human testis; mesenchymal stem cells; pluripotent stem cells; spermatogonia

Mesh:

Substances:

Year:  2013        PMID: 24214658     DOI: 10.1093/molehr/gat076

Source DB:  PubMed          Journal:  Mol Hum Reprod        ISSN: 1360-9947            Impact factor:   4.025


  20 in total

1.  AZFc deletions do not affect the function of human spermatogonia in vitro.

Authors:  B Nickkholgh; C M Korver; S K M van Daalen; A M M van Pelt; S Repping
Journal:  Mol Hum Reprod       Date:  2015-04-21       Impact factor: 4.025

Review 2.  Current stem cell based therapies in diabetes.

Authors:  Meredith A Lilly; Meghan F Davis; Josh E Fabie; Elizabeth B Terhune; G Ian Gallicano
Journal:  Am J Stem Cells       Date:  2016-10-20

Review 3.  Spermatogonial Stem Cell Culture in Oncofertility.

Authors:  Sherin David; Kyle E Orwig
Journal:  Urol Clin North Am       Date:  2020-05       Impact factor: 2.241

Review 4.  Mesenchymal Stem Cells (MSCs) Therapy for Recovery of Fertility: a Systematic Review.

Authors:  Zahra Fazeli; Atieh Abedindo; Mir Davood Omrani; Sayyed Mohammad Hossein Ghaderian
Journal:  Stem Cell Rev Rep       Date:  2018-02       Impact factor: 5.739

Review 5.  Spermatogonial stem cells.

Authors:  Hiroshi Kubota; Ralph L Brinster
Journal:  Biol Reprod       Date:  2018-07-01       Impact factor: 4.285

6.  Human Testis Extracellular Matrix Enhances Human Spermatogonial Stem Cell Survival In Vitro.

Authors:  Mark H Murdock; Sherin David; Ilea T Swinehart; Janet E Reing; Kien Tran; Kathrin Gassei; Kyle E Orwig; Stephen F Badylak
Journal:  Tissue Eng Part A       Date:  2019-04       Impact factor: 3.845

Review 7.  Pluripotent Stem Cells in Adult Tissues: Struggling To Be Acknowledged Over Two Decades.

Authors:  Deepa Bhartiya
Journal:  Stem Cell Rev Rep       Date:  2017-12       Impact factor: 5.739

8.  Sertoli Cells Possess Immunomodulatory Properties and the Ability of Mitochondrial Transfer Similar to Mesenchymal Stromal Cells.

Authors:  Bianka Porubska; Daniel Vasek; Veronika Somova; Michaela Hajkova; Michaela Hlaviznova; Tereza Tlapakova; Vladimir Holan; Magdalena Krulova
Journal:  Stem Cell Rev Rep       Date:  2021-06-11       Impact factor: 5.739

9.  In vitro generation of Sertoli-like and haploid spermatid-like cells from human umbilical cord perivascular cells.

Authors:  Ekaterina Shlush; Leila Maghen; Sonja Swanson; Shlomit Kenigsberg; Sergey Moskovtsev; Tanya Barretto; Andrée Gauthier-Fisher; Clifford L Librach
Journal:  Stem Cell Res Ther       Date:  2017-02-15       Impact factor: 6.832

10.  Identification and characterization of Xenopus tropicalis common progenitors of Sertoli and peritubular myoid cell lineages.

Authors:  Tereza Tlapakova; Thi Minh Xuan Nguyen; Marketa Vegrichtova; Monika Sidova; Karolina Strnadova; Monika Blahova; Vladimir Krylov
Journal:  Biol Open       Date:  2016-09-15       Impact factor: 2.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.